Scientists at UCLA's California NanoSystems Institute and Jonsson Comprehensive Cancer Center have combined their nanotechnology expertise to create a new treatment that may solve some of the problems of using chemotherapy ...
Bio & Medicine
Mar 24, 2015
0
390
(Phys.org) —A team of researchers at the Memorial Sloan-Kettering Cancer Center has developed a method for mass producing T cells that have been reprogrammed using stem cell technology to target and destroy cancerous tumors. ...
Biomedical researchers at Cedars-Sinai have invented a tiny drug-delivery system that can identify cancer cell types in the brain through virtual biopsies and then attack the molecular structure of the disease.
Bio & Medicine
May 26, 2015
0
598
(Phys.org) —Herceptin and camptothecin are both powerful anticancer agents with key characteristics that limit their effectiveness in treating cancer. Patients treated with Herceptin, a monoclonal antibody that targets ...
Bio & Medicine
Jul 15, 2013
0
0
The most common type of lung cancer, non-small cell lung cancer (NSCLC), continues to be difficult to treat, with five year survival rates of about 36 percent for stage 3A tumors. Jefferson College of Pharmacy researchers ...
Bio & Medicine
Apr 11, 2018
0
705
(Phys.org) —Activating the body's immune system to attack cancer and prevent it from recurring is one of the Holy Grails of cancer research because of its ability to specifically target cancer and to search almost anywhere ...
Bio & Medicine
Jul 15, 2013
0
0
Researchers at the University of Michigan have had initial success in mice using nanodiscs to deliver a customized therapeutic vaccine for the treatment of colon and melanoma cancer tumors.
Bio & Medicine
Dec 26, 2016
0
406
Tumor markers are biological substances, usually proteins, that provide early indication of cancerous or benign tumors in the body.
Bio & Medicine
Sep 22, 2015
0
65
Researchers at UT Southwestern Medical Center have identified a cellular switch that potentially can be turned off and on to slow down, and eventually inhibit the growth of the most commonly diagnosed and aggressive malignant ...
Cell & Microbiology
Sep 20, 2013
0
0
A team of researchers from Cornell University in Ithaca, New York demonstrated a drug delivery mechanism that utilizes two independent vehicles, allowing for delivery of chemically and physically dis-tinct agents.
Bio & Medicine
May 20, 2016
0
11
